PALANTIR TECHNOLOGIES INC-A (PTX.DE) Stock Fundamental Analysis

FRA:PTX • US69608A1088

111.46 EUR
+1.08 (+0.98%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to PTX. PTX was compared to 117 industry peers in the Software industry. Both the health and profitability get an excellent rating, making PTX a very profitable company, without any liquidiy or solvency issues. PTX is valued quite expensively, but it does show have an excellent growth rating. These ratings would make PTX suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year PTX was profitable.
  • PTX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PTX reported negative net income in multiple years.
  • Each year in the past 5 years PTX had a positive operating cash flow.
PTX.DE Yearly Net Income VS EBIT VS OCF VS FCFPTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • The Return On Assets of PTX (18.26%) is better than 90.60% of its industry peers.
  • PTX has a Return On Equity of 22.00%. This is in the better half of the industry: PTX outperforms 79.49% of its industry peers.
  • The Return On Invested Capital of PTX (12.89%) is better than 76.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PTX is significantly below the industry average of 13.32%.
  • The last Return On Invested Capital (12.89%) for PTX is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROIC 12.89%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
PTX.DE Yearly ROA, ROE, ROICPTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • PTX's Profit Margin of 36.31% is amongst the best of the industry. PTX outperforms 91.45% of its industry peers.
  • Looking at the Operating Margin, with a value of 31.59%, PTX belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • PTX's Gross Margin of 82.37% is fine compared to the rest of the industry. PTX outperforms 70.09% of its industry peers.
  • In the last couple of years the Gross Margin of PTX has grown nicely.
Industry RankSector Rank
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
PTX.DE Yearly Profit, Operating, Gross MarginsPTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PTX is still creating some value.
  • Compared to 1 year ago, PTX has more shares outstanding
  • Compared to 5 years ago, PTX has more shares outstanding
  • PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PTX.DE Yearly Shares OutstandingPTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
PTX.DE Yearly Total Debt VS Total AssetsPTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • PTX has an Altman-Z score of 125.06. This indicates that PTX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PTX (125.06) is better than 100.00% of its industry peers.
  • PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 125.06
ROIC/WACC1.17
WACC10.98%
PTX.DE Yearly LT Debt VS Equity VS FCFPTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 7.11 indicates that PTX has no problem at all paying its short term obligations.
  • The Current ratio of PTX (7.11) is better than 92.31% of its industry peers.
  • PTX has a Quick Ratio of 7.11. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
  • PTX has a Quick ratio of 7.11. This is amongst the best in the industry. PTX outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 7.11
Quick Ratio 7.11
PTX.DE Yearly Current Assets VS Current LiabilitesPTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 82.93% over the past year.
  • Measured over the past years, PTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 132.08% on average per year.
  • Looking at the last year, PTX shows a very strong growth in Revenue. The Revenue has grown by 56.18%.
  • The Revenue has been growing by 32.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%

3.2 Future

  • Based on estimates for the next years, PTX will show a very strong growth in Earnings Per Share. The EPS will grow by 37.01% on average per year.
  • Based on estimates for the next years, PTX will show a very strong growth in Revenue. The Revenue will grow by 38.98% on average per year.
EPS Next Y48.83%
EPS Next 2Y46.21%
EPS Next 3Y43.66%
EPS Next 5Y37.01%
Revenue Next Year48.7%
Revenue Next 2Y44.38%
Revenue Next 3Y45%
Revenue Next 5Y38.98%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PTX.DE Yearly Revenue VS EstimatesPTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B
PTX.DE Yearly EPS VS EstimatesPTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 176.92, the valuation of PTX can be described as expensive.
  • 62.39% of the companies in the same industry are cheaper than PTX, based on the Price/Earnings ratio.
  • PTX is valuated expensively when we compare the Price/Earnings ratio to 27.16, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 118.38, the valuation of PTX can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PTX indicates a slightly more expensive valuation: PTX is more expensive than 65.81% of the companies listed in the same industry.
  • PTX is valuated expensively when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 176.92
Fwd PE 118.38
PTX.DE Price Earnings VS Forward Price EarningsPTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PTX is valued a bit more expensive than the industry average as 70.09% of the companies are valued more cheaply.
  • 61.54% of the companies in the same industry are cheaper than PTX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 149.86
EV/EBITDA 207.49
PTX.DE Per share dataPTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
  • PTX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PTX's earnings are expected to grow with 43.66% in the coming years.
PEG (NY)3.62
PEG (5Y)N/A
EPS Next 2Y46.21%
EPS Next 3Y43.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PTX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (2/17/2026, 7:00:00 PM)

111.46

+1.08 (+0.98%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-02
Earnings (Next)05-04
Inst Owners60.07%
Inst Owner ChangeN/A
Ins Owners3.54%
Ins Owner ChangeN/A
Market Cap265.55B
Revenue(TTM)4.48B
Net Income(TTM)1.63B
Analysts68.48
Price Target164.56 (47.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.36%
Min EPS beat(2)6.45%
Max EPS beat(2)22.26%
EPS beat(4)3
Avg EPS beat(4)10.5%
Min EPS beat(4)-0.58%
Max EPS beat(4)22.26%
EPS beat(8)7
Avg EPS beat(8)10.39%
EPS beat(12)10
Avg EPS beat(12)10.73%
EPS beat(16)11
Avg EPS beat(16)-2.66%
Revenue beat(2)2
Avg Revenue beat(2)5.12%
Min Revenue beat(2)4.21%
Max Revenue beat(2)6.02%
Revenue beat(4)4
Avg Revenue beat(4)3.84%
Min Revenue beat(4)0.43%
Max Revenue beat(4)6.02%
Revenue beat(8)7
Avg Revenue beat(8)2.81%
Revenue beat(12)8
Avg Revenue beat(12)1.65%
Revenue beat(16)8
Avg Revenue beat(16)0.99%
PT rev (1m)3.01%
PT rev (3m)25.97%
EPS NQ rev (1m)36.07%
EPS NQ rev (3m)38.87%
EPS NY rev (1m)8.4%
EPS NY rev (3m)28.86%
Revenue NQ rev (1m)16.9%
Revenue NQ rev (3m)18.58%
Revenue NY rev (1m)5.37%
Revenue NY rev (3m)14.42%
Valuation
Industry RankSector Rank
PE 176.92
Fwd PE 118.38
P/S 70.34
P/FCF 149.86
P/OCF 147.49
P/B 42.61
P/tB 42.61
EV/EBITDA 207.49
EPS(TTM)0.63
EY0.57%
EPS(NY)0.94
Fwd EY0.84%
FCF(TTM)0.74
FCFY0.67%
OCF(TTM)0.76
OCFY0.68%
SpS1.58
BVpS2.62
TBVpS2.62
PEG (NY)3.62
PEG (5Y)N/A
Graham Number6.09
Profitability
Industry RankSector Rank
ROA 18.26%
ROE 22%
ROCE 18.3%
ROIC 12.89%
ROICexc 181.73%
ROICexgc 181.73%
OM 31.59%
PM (TTM) 36.31%
GM 82.37%
FCFM 46.94%
ROA(3y)10.06%
ROA(5y)0.67%
ROE(3y)12.42%
ROE(5y)0%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)151.52%
ROICexc(5y)N/A
ROICexgc(3y)172.69%
ROICexgc(5y)N/A
ROCE(3y)9.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.59%
GM growth 5Y3.99%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.59%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 148.21%
Profit Quality 129.26%
Current Ratio 7.11
Quick Ratio 7.11
Altman-Z 125.06
F-Score8
WACC10.98%
ROIC/WACC1.17
Cap/Depr(3y)71.63%
Cap/Depr(5y)95.48%
Cap/Sales(3y)0.63%
Cap/Sales(5y)0.96%
Profit Quality(3y)236.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.93%
EPS 3Y132.08%
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y48.83%
EPS Next 2Y46.21%
EPS Next 3Y43.66%
EPS Next 5Y37.01%
Revenue 1Y (TTM)56.18%
Revenue growth 3Y32.92%
Revenue growth 5Y32.58%
Sales Q2Q%70%
Revenue Next Year48.7%
Revenue Next 2Y44.38%
Revenue Next 3Y45%
Revenue Next 5Y38.98%
EBIT growth 1Y355.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.84%
EBIT Next 3Y-5.79%
EBIT Next 5Y2.84%
FCF growth 1Y84.06%
FCF growth 3Y125.29%
FCF growth 5YN/A
OCF growth 1Y84.98%
OCF growth 3Y112.09%
OCF growth 5YN/A

PALANTIR TECHNOLOGIES INC-A / PTX.DE FAQ

What is the ChartMill fundamental rating of PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PTX.DE.


What is the valuation status for PTX stock?

ChartMill assigns a valuation rating of 1 / 10 to PALANTIR TECHNOLOGIES INC-A (PTX.DE). This can be considered as Overvalued.


How profitable is PALANTIR TECHNOLOGIES INC-A (PTX.DE) stock?

PALANTIR TECHNOLOGIES INC-A (PTX.DE) has a profitability rating of 7 / 10.


How financially healthy is PALANTIR TECHNOLOGIES INC-A?

The financial health rating of PALANTIR TECHNOLOGIES INC-A (PTX.DE) is 9 / 10.